drugset / Trial / NCT03343327
A Study of Chronocort® Versus Cortef ® in Healthy Adult Male Subjects
Phase 1
Completed
25 enrolled
Neurocrine UK Limited
Bionical Emas · collabBrush Clinical Research Ltd. · collabMedical Matters International Ltd · collabSimbec Research · collabVoet Consulting · collab
RandomizedCrossoverOpen-labelTreatment
Summary
This was a single centre, open label, randomised, two period, crossover study to evaluate the bioavailability of Chronocort® versus Cortef® immediate release hydrocortisone tablets in dexamethasone-suppressed healthy adult male subjects.
Timeline
- Start
- 2018-02-19
- Primary completion
- 2018-04-20
- Completion
- 2018-04-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Chronocort | Unknown | 20 mg | Oral |
| Subject | Hydrocortisone | Other / unclassified | 20 mg | — |